Vimarsana
Biggest News Aggregation in the World

Page 33 - General Catalyst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from General Catalyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In General Catalyst Today - Breaking & Trending Today

Grasshopper Partners With Greenlite For AI-Powered Enhanced Due Diligence ... - Vimarsana News

Grasshopper Partners With Greenlite For AI-Powered Enhanced Due Diligence ...

Grasshopper Partners With Greenlite For AI-Powered Enhanced Due Diligence ...

Exclusive: How to get (and keep) a VC job, with Bessemer partner Jeremy Levine - Vimarsana News

Exclusive: How to get (and keep) a VC job, with Bessemer partner Jeremy Levine

Bessemer is getting ready to open applications for its apprenticeship program. Here’s what the firm looks for—plus, insights into Bessemer's decision-making process.

MedCity News Launches Debunked, A Show Where We Slaughter Myths, Bad Practices and Sacred Cows in Healthcare - Vimarsana News

MedCity News Launches Debunked, A Show Where We Slaughter Myths, Bad Practices and Sacred Cows in Healthcare

MedCity News is launching a new ongoing show called Debunked: Slaughtering Myths, Bad Practices and Sacred Cows in Healthcare. In this show, co-hosts Arundhati Parmar and Samir Batra will discuss healthcare news and call out things that seem utterly insane to us. The goal is to inspire change in the healthcare industry.

Fractyl Health prices US IPO below range to raise $110 mln - Vimarsana News

Fractyl Health prices US IPO below range to raise $110 mln

Obesity and diabetes drug developer Fractyl Health on Thursday priced its U.S. initial public offering below an indicated range to raise $110 million. The company, backed by Investment...

Fractyl Health valued at $654.6 mln in tepid debut - Vimarsana News

Fractyl Health valued at $654.6 mln in tepid debut

Shares of Fractyl Health fell 8.3% on their market debut on Friday, giving the obesity and diabetes drug developer a market capitalization of $654.6 million. After a two-year lull,...